TABLE 1.
Patient | Gender | Age (years) | Smoking status | GOLD stage | Treatment |
#1 | M | 84 | Former | 3 | Corticosteroid + LABA + LAMA |
#2 | M | 72 | Former | 3 | LABA + LAMA |
#3 | F | 71 | Former | 2 | LABA + LAMA |
#4 | M | 63 | Smoker | 3 | Corticosteroid + LABA + LAMA |
#5 | F | 44 | Smoker | 1 | Corticosteroid + LABA |
#6 | M | 76 | No Smoker | 2 | Corticosteroid + LABA + LAMA |
#7 | F | 75 | Former | 2 | Corticosteroid + LABA + LAMA |
#8 | M | 69 | Former | 3 | Corticosteroid + LABA + LAMA |
LABA, long-acting β2-agonist; LAMA, long-acting anti-muscarinic agent.